Number of responders in the combination antimicrobial groups versus number of responders in the placebo group Month 6 [clinicaltrials_resource:4b151bac73f3d46697d3c454fdeaeba5]
Participants will receive Azithromycin and Rifampin
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of responders in the combination antimicrobial groups versus number of responders in the placebo group Month 6 [clinicaltrials_resource:4b151bac73f3d46697d3c454fdeaeba5]
Participants will receive Azithromycin and Rifampin
Bio2RDF identifier
4b151bac73f3d46697d3c454fdeaeba5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4b151bac73f3d46697d3c454fdeaeba5
measure [clinicaltrials_vocabulary:measure]
Number of responders in the co ...... esponders in the placebo group
time frame [clinicaltrials_vocabulary:time-frame]
description
Participants will receive Azithromycin and Rifampin
identifier
clinicaltrials_resource:4b151bac73f3d46697d3c454fdeaeba5
title
Number of responders in the co ...... s in the placebo group Month 6
@en
type
label
Number of responders in the co ...... 51bac73f3d46697d3c454fdeaeba5]
@en